Xenetic Biosciences, Inc. (XBIO) stock
XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)
Close on Nov 17, 2026Market cap $3.77MP/E –Yield –
Xenetic Biosciences total assets
Total assets on the balance sheet at the end of each period.
Xenetic Biosciences's total assets was $6.97M at Jun 30, 2026. For fiscal 2025 it was $8.36M, up 21.2% from the year before. Over ten years it grew -6.8% a year on average. The highest annual figure on record is $25.37M in fiscal 2012.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.36M | +21.2% |
| FY2024 | Dec 31, 2024 | $6.90M | -34.9% |
| FY2023 | Dec 31, 2023 | $10.61M | -28.0% |
| FY2022 | Dec 31, 2022 | $14.72M | -25.7% |
| FY2021 | Dec 31, 2021 | $19.82M | +50.3% |
| FY2020 | Dec 31, 2020 | $13.18M | -38.8% |
| FY2019 | Dec 31, 2019 | $21.55M | +49.3% |
| FY2018 | Dec 31, 2018 | $14.43M | -24.7% |
| FY2017 | Dec 31, 2017 | $19.16M | -8.6% |
| FY2016 | Dec 31, 2016 | $20.97M | +24.0% |
| FY2015 | Dec 31, 2015 | $16.91M | +3.6% |
| FY2014 | Dec 31, 2014 | $16.32M | -16.2% |
| FY2013 | Dec 31, 2013 | $19.47M | -23.3% |
| FY2012 | Dec 31, 2012 | $25.37M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.97M | +30.2% |
| Q1 FY2026 | Mar 31, 2026 | $7.91M | +36.6% |
| Q4 FY2025 | Dec 31, 2025 | $8.36M | +21.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.07M | -37.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.35M | -40.7% |
| Q1 FY2025 | Mar 31, 2025 | $5.79M | -38.4% |
| Q4 FY2024 | Dec 31, 2024 | $6.90M | -34.9% |
| Q3 FY2024 | Sep 30, 2024 | $8.05M | -32.7% |
| Q2 FY2024 | Jun 30, 2024 | $9.03M | -29.1% |
| Q1 FY2024 | Mar 31, 2024 | $9.39M | -31.5% |
| Q4 FY2023 | Dec 31, 2023 | $10.61M | -28.0% |
| Q3 FY2023 | Sep 30, 2023 | $11.96M | -27.4% |
| Q2 FY2023 | Jun 30, 2023 | $12.75M | -29.1% |
| Q1 FY2023 | Mar 31, 2023 | $13.72M | -30.8% |
| Q4 FY2022 | Dec 31, 2022 | $14.72M | -30.8% |
| Q2 FY2022 | Jun 30, 2022 | $16.47M | +50.9% |
| Q1 FY2022 | Mar 31, 2022 | $17.98M | +52.9% |
| Q4 FY2021 | Dec 31, 2021 | $19.82M | +50.3% |
| Q3 FY2021 | Sep 30, 2021 | $21.29M | +144.8% |
| Q2 FY2021 | Jun 30, 2021 | $10.92M | -42.7% |
| Q1 FY2021 | Mar 31, 2021 | $11.76M | -43.0% |
| Q4 FY2020 | Dec 31, 2020 | $13.18M | -38.8% |
| Q3 FY2020 | Sep 30, 2020 | $8.70M | -62.0% |
| Q2 FY2020 | Jun 30, 2020 | $19.06M | +21.9% |
| Q1 FY2020 | Mar 31, 2020 | $20.63M | +25.3% |
| Q4 FY2019 | Dec 31, 2019 | $21.55M | +49.3% |
| Q3 FY2019 | Sep 30, 2019 | $22.88M | +47.3% |
| Q2 FY2019 | Jun 30, 2019 | $15.63M | -9.4% |
| Q1 FY2019 | Mar 31, 2019 | $16.46M | -6.2% |
| Q4 FY2018 | Dec 31, 2018 | $14.43M | -24.7% |
| Q3 FY2018 | Sep 30, 2018 | $15.53M | +6.1% |
| Q2 FY2018 | Jun 30, 2018 | $17.26M | +5.0% |
| Q1 FY2018 | Mar 31, 2018 | $17.54M | -6.8% |
| Q4 FY2017 | Dec 31, 2017 | $19.16M | -8.6% |
| Q3 FY2017 | Sep 30, 2017 | $14.64M | +5.6% |
| Q2 FY2017 | Jun 30, 2017 | $16.44M | +24.9% |
| Q1 FY2017 | Mar 31, 2017 | $18.83M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.97M | – |
| Q3 FY2016 | Sep 30, 2016 | $13.87M | – |
| Q2 FY2016 | Jun 30, 2016 | $13.16M | – |
See a number that looks wrong?